Christopher D. Dupont

1.0k total citations
23 papers, 779 citations indexed

About

Christopher D. Dupont is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Christopher D. Dupont has authored 23 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Christopher D. Dupont's work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Toxoplasma gondii Research Studies (6 papers). Christopher D. Dupont is often cited by papers focused on CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Toxoplasma gondii Research Studies (6 papers). Christopher D. Dupont collaborates with scholars based in United States, France and Canada. Christopher D. Dupont's co-authors include Christopher A. Hunter, David A. Christian, John J. O’Shea, Golnaz Vahedi, Kamran Ghoreschi, Giuseppe Sciumè, Qian Chen, Kiyoshi Hirahara, Loise M. Francisco and Masao Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Christopher D. Dupont

22 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher D. Dupont United States 11 373 316 307 146 134 23 779
Valentina Martín Argentina 16 508 1.4× 186 0.6× 387 1.3× 198 1.4× 50 0.4× 33 809
Lisa A. King France 15 139 0.4× 230 0.7× 145 0.5× 118 0.8× 169 1.3× 27 714
Shiguang Huang China 17 323 0.9× 262 0.8× 226 0.7× 131 0.9× 36 0.3× 47 723
Mohammad Zare‐Bidaki Iran 16 131 0.4× 192 0.6× 157 0.5× 119 0.8× 43 0.3× 45 568
Alan Sher United States 13 426 1.1× 302 1.0× 172 0.6× 102 0.7× 84 0.6× 23 979
Rogier Gaiser United States 9 288 0.8× 114 0.4× 253 0.8× 224 1.5× 170 1.3× 12 650
Erika Lamb United States 9 229 0.6× 418 1.3× 120 0.4× 77 0.5× 65 0.5× 9 707
Naganori Kamiyama Japan 9 302 0.8× 292 0.9× 309 1.0× 281 1.9× 35 0.3× 23 756
Keke C. Fairfax United States 12 242 0.6× 362 1.1× 64 0.2× 118 0.8× 45 0.3× 22 812
Megumi Okuyama Japan 10 408 1.1× 367 1.2× 457 1.5× 329 2.3× 30 0.2× 12 1.0k

Countries citing papers authored by Christopher D. Dupont

Since Specialization
Citations

This map shows the geographic impact of Christopher D. Dupont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Dupont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Dupont more than expected).

Fields of papers citing papers by Christopher D. Dupont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Dupont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Dupont. The network helps show where Christopher D. Dupont may publish in the future.

Co-authorship network of co-authors of Christopher D. Dupont

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Dupont. A scholar is included among the top collaborators of Christopher D. Dupont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Dupont. Christopher D. Dupont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Falchook, Gerald S., Robert Wesolowski, Hatem Soliman, et al.. (2024). 658P First-in-human phase I trial of oncolytic herpes simplex virus ONCR-177 alone or in combination with pembrolizumab in advanced solid tumors. Annals of Oncology. 35. S519–S519. 2 indexed citations
3.
Dupont, Christopher D., Natalie Bath, Megan Butler, et al.. (2024). 368 Translational analyses reveal mechanisms of afami-cel’s anti-tumor activity in synovial sarcoma. Regular and Young Investigator Award Abstracts. A424–A424. 1 indexed citations
4.
Park, Jong Chul, Hatem Soliman, Gerald S. Falchook, et al.. (2021). 511 Initial results of a phase 1 study of intratumoral ONCR-177, an oncolytic herpes-simplex virus-1 expressing five immunomodulatory transgenes, in subjects with advanced injectable tumors. SHILAP Revista de lepidopterología. A542–A542. 9 indexed citations
5.
Dupont, Christopher D., Ingrid L. Scully, Brinda Monian, et al.. (2018). Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response. mSphere. 3(4). 16 indexed citations
6.
Wilky, Breelyn A., Priya Kumthekar, Robert Wesolowski, et al.. (2018). Phase I, open-label ascending dose trial of anti–CTLA-4 monoclonal antibody AGEN1884 in advanced solid malignancies, with expansion to patients refractory to recent anti–PD-1/PD-L1 therapy. Annals of Oncology. 29. viii416–viii417. 2 indexed citations
7.
Wilky, Breelyn A., Priya Kumthekar, Robert Wesolowski, et al.. (2018). Phase I open-label, ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies: Dose selection for combination with PD-1 blockade.. Journal of Clinical Oncology. 36(15_suppl). 3075–3075. 2 indexed citations
8.
Coward, Jermaine, Charlotte Lemech, Tarek Meniawy, et al.. (2018). Phase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors. Annals of Oncology. 29. viii417–viii417. 3 indexed citations
9.
10.
11.
Dupont, Christopher D., Gretchen Harms Pritchard, Shinya Hidano, et al.. (2015). Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis. The Journal of Immunology. 195(9). 4369–4377. 13 indexed citations
12.
Dupont, Christopher D., David A. Christian, Elizabeth M. Selleck, et al.. (2014). Parasite Fate and Involvement of Infected Cells in the Induction of CD4+ and CD8+ T Cell Responses to Toxoplasma gondii. PLoS Pathogens. 10(4). e1004047–e1004047. 77 indexed citations
13.
Mishra, Satish, Christopher D. Dupont, Melissa S. Love, et al.. (2013). A Host GPCR Signaling Network Required for the Cytolysis of Infected Cells Facilitates Release of Apicomplexan Parasites. Cell Host & Microbe. 13(1). 15–28. 31 indexed citations
14.
Rouveix, É., et al.. (2013). Faible taux de couverture vaccinale contre la grippe des sujets âgés hospitalisés en France. La Revue de Médecine Interne. 34(12). 730–734. 5 indexed citations
15.
Dupont, Christopher D., David A. Christian, & Christopher A. Hunter. (2012). Immune response and immunopathology during toxoplasmosis. Seminars in Immunopathology. 34(6). 793–813. 267 indexed citations
16.
Rouveix, É., et al.. (2012). Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in France. Médecine et Maladies Infectieuses. 43(1). 22–27. 11 indexed citations
17.
Hirahara, Kiyoshi, Kamran Ghoreschi, Xiang‐Ping Yang, et al.. (2012). Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1. Immunity. 36(6). 1017–1030. 210 indexed citations
18.
Jordan, Kimberly A., Christopher D. Dupont, Elia D. Tait Wojno, Hsiou‐Chi Liou, & Christopher A. Hunter. (2010). Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii. International Immunology. 22(11). 851–861. 11 indexed citations
19.
Wojno, Elia D. Tait, Kimberly A. Jordan, Christopher D. Dupont, et al.. (2010). Virulence of Toxoplasma gondii Is Associated with Distinct Dendritic Cell Responses and Reduced Numbers of Activated CD8+ T Cells. The Journal of Immunology. 185(3). 1502–1512. 39 indexed citations
20.
Paubert-Braquet, M., et al.. (1994). Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells.. PubMed. 9(3). 285–90. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Martín Breakdown of academic impact, for papers by Lisa A. King Breakdown of academic impact, for papers by Shiguang Huang Breakdown of academic impact, for papers by Mohammad Zare‐Bidaki Breakdown of academic impact, for papers by Alan Sher Breakdown of academic impact, for papers by Rogier Gaiser Breakdown of academic impact, for papers by Erika Lamb Breakdown of academic impact, for papers by Naganori Kamiyama Breakdown of academic impact, for papers by Keke C. Fairfax Breakdown of academic impact, for papers by Megumi Okuyama
Rankless by CCL
2026